AI Drug Discovery

Insilico Medicine has launched a DDD Benchmark as a Service to test frontier AI and foundation models against real-world drug discovery and development tasks.

OpenAI researcher Miles Wang is reportedly launching an AI drug discovery startup, highlighting surging investor demand for life sciences AI.

Isomorphic Labs, a Google DeepMind spinoff, will soon start human trials of drugs designed using its Nobel Prize–winning AI protein-folding technology.

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers evaluate the growing flood of AI-generated potential drug molecules.

Isomorphic Labs, the DeepMind spin-off focused on AI-driven drug discovery, has revealed an exclusive new AI model that scientists say surpasses current benchmarks, offering a glimpse of what AlphaFold 4 may bring to pharmaceutical research and molecular biology.

Merck partners with Mayo Clinic to leverage AI, advanced analytics, and the Mayo Clinic Platform's genomic and clinical data for drug discovery and precision medicine. The collaboration initially targets inflammatory bowel disease, atopic dermatitis, and multiple sclerosis.

Demis Hassabis reveals 17 AI drug development projects at Davos, predicting robotics breakthrough and golden age of scientific discovery.

AI biotech startup Chai Discovery completes Series B funding and announces partnership with Eli Lilly to accelerate drug discovery using generative design models.